Chintal H Shah, Rajesh Balkrishnan, Vakaramoko Diaby, Hong Xiao. Res Social Adm Pharm 2020
Times Cited: 2
Times Cited: 2
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
50
Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
50
Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Ahmedin Jemal, Anthony S Robbins, Chun Chieh Lin, W Dana Flanders, Carol E DeSantis, Elizabeth M Ward, Rachel A Freedman. J Clin Oncol 2018
Ahmedin Jemal, Anthony S Robbins, Chun Chieh Lin, W Dana Flanders, Carol E DeSantis, Elizabeth M Ward, Rachel A Freedman. J Clin Oncol 2018
50
Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.
T Fujii, T Kogawa, W Dong, A A Sahin, S Moulder, J K Litton, D Tripathy, T Iwamoto, K K Hunt, L Pusztai,[...]. Ann Oncol 2017
T Fujii, T Kogawa, W Dong, A A Sahin, S Moulder, J K Litton, D Tripathy, T Iwamoto, K K Hunt, L Pusztai,[...]. Ann Oncol 2017
50
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.
Hope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, Debu Tripathy, Peter A Kaufman, Musa Mayer, Bongin Yoo, Oyewale O Abidoye, Denise A Yardley. Breast Cancer Res Treat 2013
Hope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, Debu Tripathy, Peter A Kaufman, Musa Mayer, Bongin Yoo, Oyewale O Abidoye, Denise A Yardley. Breast Cancer Res Treat 2013
50
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
50
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Huiyan Ma, Yani Lu, Kathleen E Malone, Polly A Marchbanks, Dennis M Deapen, Robert Spirtas, Ronald T Burkman, Brian L Strom, Jill A McDonald, Suzanne G Folger,[...]. BMC Cancer 2013
Huiyan Ma, Yani Lu, Kathleen E Malone, Polly A Marchbanks, Dennis M Deapen, Robert Spirtas, Ronald T Burkman, Brian L Strom, Jill A McDonald, Suzanne G Folger,[...]. BMC Cancer 2013
50
Steroid-hormone receptors and survival after first relapse in breast cancer.
A Howell, D M Barnes, R N Harland, J Redford, V H Bramwell, M J Wilkinson, R Swindell, D Crowther, R A Sellwood. Lancet 1984
A Howell, D M Barnes, R N Harland, J Redford, V H Bramwell, M J Wilkinson, R Swindell, D Crowther, R A Sellwood. Lancet 1984
50
Breast cancer version 3.2014.
William J Gradishar, Benjamin O Anderson, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano, Lori J Goldstein,[...]. J Natl Compr Canc Netw 2014
William J Gradishar, Benjamin O Anderson, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano, Lori J Goldstein,[...]. J Natl Compr Canc Netw 2014
50
Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006
50
A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change.
Bobby Daly, Olufunmilayo I Olopade. CA Cancer J Clin 2015
Bobby Daly, Olufunmilayo I Olopade. CA Cancer J Clin 2015
50
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003
50
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Huiyan Ma, Yani Lu, Polly A Marchbanks, Suzanne G Folger, Brian L Strom, Jill A McDonald, Michael S Simon, Linda K Weiss, Kathleen E Malone, Ronald T Burkman,[...]. Breast Cancer Res 2013
Huiyan Ma, Yani Lu, Polly A Marchbanks, Suzanne G Folger, Brian L Strom, Jill A McDonald, Michael S Simon, Linda K Weiss, Kathleen E Malone, Ronald T Burkman,[...]. Breast Cancer Res 2013
50
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.
G M Clark, G W Sledge, C K Osborne, W L McGuire. J Clin Oncol 1987
G M Clark, G W Sledge, C K Osborne, W L McGuire. J Clin Oncol 1987
50
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
50
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.
R A Deyo, D C Cherkin, M A Ciol. J Clin Epidemiol 1992
R A Deyo, D C Cherkin, M A Ciol. J Clin Epidemiol 1992
50
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
50
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018
50
Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer.
Nadia Harbeck, Achim Rody. J Clin Oncol 2012
Nadia Harbeck, Achim Rody. J Clin Oncol 2012
50
Literature review of data-based models for identification of factors associated with racial disparities in breast cancer mortality.
Diana Prieto, Milton Soto-Ferrari, Rindy Tija, Lorena Peña, Leandra Burke, Lisa Miller, Kelsey Berndt, Brian Hill, Jafar Haghsenas, Ethan Maltz,[...]. Health Syst (Basingstoke) 2018
Diana Prieto, Milton Soto-Ferrari, Rindy Tija, Lorena Peña, Leandra Burke, Lisa Miller, Kelsey Berndt, Brian Hill, Jafar Haghsenas, Ethan Maltz,[...]. Health Syst (Basingstoke) 2018
100
Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
50
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients.
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999
50
Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women.
Halei C Benefield, Emma H Allott, Katherine E Reeder-Hayes, Charles M Perou, Lisa A Carey, Joseph Geradts, Xuezheng Sun, Benjamin C Calhoun, Melissa A Troester. J Natl Cancer Inst 2020
Halei C Benefield, Emma H Allott, Katherine E Reeder-Hayes, Charles M Perou, Lisa A Carey, Joseph Geradts, Xuezheng Sun, Benjamin C Calhoun, Melissa A Troester. J Natl Cancer Inst 2020
50
Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.
Stephanie B Wheeler, Katherine E Reeder-Hayes, Lisa A Carey. Oncologist 2013
Stephanie B Wheeler, Katherine E Reeder-Hayes, Lisa A Carey. Oncologist 2013
50
Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population.
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014
50
Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015
50
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
Valerie-Jeanne Bardou, Grazia Arpino, Richard M Elledge, C Kent Osborne, Gary M Clark. J Clin Oncol 2003
Valerie-Jeanne Bardou, Grazia Arpino, Richard M Elledge, C Kent Osborne, Gary M Clark. J Clin Oncol 2003
50
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
50
Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Moriah J Brier, Dianne L Chambless, Robert Gross, Jinbo Chen, Jun J Mao. Cancer 2017
Moriah J Brier, Dianne L Chambless, Robert Gross, Jinbo Chen, Jun J Mao. Cancer 2017
50
Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.
K Thompson, J Kulkarni, A A Sergejew. Schizophr Res 2000
K Thompson, J Kulkarni, A A Sergejew. Schizophr Res 2000
50
Determinants affecting medication adherence in the elderly: A qualitative study.
Peivand Bastani, Parisa Bikineh, Ramin Ravangard, Rita Rezaee, Zahra Kavosi. Aging Med (Milton) 2020
Peivand Bastani, Parisa Bikineh, Ramin Ravangard, Rita Rezaee, Zahra Kavosi. Aging Med (Milton) 2020
100
Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review.
Suhila Sawesi, Janet S Carpenter, Josette Jones. Clin J Oncol Nurs 2014
Suhila Sawesi, Janet S Carpenter, Josette Jones. Clin J Oncol Nurs 2014
50
Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly. Breast Cancer Res Treat 2013
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly. Breast Cancer Res Treat 2013
50
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
Rebecca L Sedjo, Scott Devine. Breast Cancer Res Treat 2011
Rebecca L Sedjo, Scott Devine. Breast Cancer Res Treat 2011
50
How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.
Maurice J Berkowitz, Carlie K Thompson, Laura T Zibecchi, Minna K Lee, Elani Streja, Jacob S Berkowitz, Cachet M Wenziger, Jennifer L Baker, Maggie L DiNome, Deanna J Attai. J Cancer Surviv 2021
Maurice J Berkowitz, Carlie K Thompson, Laura T Zibecchi, Minna K Lee, Elani Streja, Jacob S Berkowitz, Cachet M Wenziger, Jennifer L Baker, Maggie L DiNome, Deanna J Attai. J Cancer Surviv 2021
50
A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer.
T I Barron, C Cahir, L Sharp, K Bennett. Br J Cancer 2013
T I Barron, C Cahir, L Sharp, K Bennett. Br J Cancer 2013
50
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.